** Shares of XtalPi Holdings 2228.HK rise 6.2% to HK$6.2, their highest level since March 31
** Drug discovery and intelligent automation solutions provider completes acquisition of UK's Liverpool ChiroChem (LCC) Technologies
** Liverpool ChiroChem designs and synthesises tech research and development of novel molecules, especially new chiral molecules
** XtalPi says acquisition will increase its technical strength in chemical space exploration and improves its ability to serve domestic and international customers
** Hong Kong's healthcare index .HSCIH rises 3.6%, Hang Seng Biotech Index .HSHKBIO surges 3.9%
** YTD, stock up 1%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。